Tectonic Therapeutic, Inc.

Tectonic Therapeutic, Inc. company information, Employees & Contact Information

Tectonic is focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-Protein Coupled Receptors. We have developed a proprietary technology platform called GEODe™ to enable the discovery and development of GPCR-targeted biologic medicines that can modify the course of disease, by addressing challenges that have limited the pace of innovation in this field. Our focus is on areas of significant unmet medical need, often where therapeutic options are poor or nonexistent, as these are areas where new medicines have the potential to improve patient quality of life.
Looking for a particular Tectonic Therapeutic, Inc. employee's phone or email?

Tectonic Therapeutic, Inc. Questions

News

Tectonic Therapeutic To Present on May 15th, 2025 at the Bank of America Securities Health Care Conference - GlobeNewswire

Tectonic Therapeutic To Present on May 15th, 2025 at the Bank of America Securities Health Care Conference GlobeNewswire

Tectonic Therapeutic Announces Closing of Merger with AVROBIO as well as Concurrent Private Placement of $130.7 Million - Business Wire

Tectonic Therapeutic Announces Closing of Merger with AVROBIO as well as Concurrent Private Placement of $130.7 Million Business Wire

Tectonic Therapeutic Announces Second Quarter 2024 Financial Results and Recent Business Highlights - Yahoo Finance

Tectonic Therapeutic Announces Second Quarter 2024 Financial Results and Recent Business Highlights Yahoo Finance

GPCR-focused Biotech Tectonic Therapeutic Sets Major Conference Schedule: CEO, CFO to Present - Stock Titan

GPCR-focused Biotech Tectonic Therapeutic Sets Major Conference Schedule: CEO, CFO to Present Stock Titan

Tectonic Therapeutic Reports Positive Interim Data on TX45 for Treatment of Group 2 Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction - Nasdaq

Tectonic Therapeutic Reports Positive Interim Data on TX45 for Treatment of Group 2 Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction Nasdaq

Tectonic Therapeutic to Present Phase 1b Data for TX45 at European Society of Cardiology Heart Failure 2025 - Yahoo Finance

Tectonic Therapeutic to Present Phase 1b Data for TX45 at European Society of Cardiology Heart Failure 2025 Yahoo Finance

Tectonic Clinical Trial Success: TX45 Shows 19% PCWP Drop, Plans New PH-ILD Phase 2 Study - Stock Titan

Tectonic Clinical Trial Success: TX45 Shows 19% PCWP Drop, Plans New PH-ILD Phase 2 Study Stock Titan

Tectonic Therapeutic Announces Start of First Clinical Program for GPCR-Targeted Biologic - Business Wire

Tectonic Therapeutic Announces Start of First Clinical Program for GPCR-Targeted Biologic Business Wire

AVROBIO and Tectonic Therapeutic Announce Merger - Business Wire

AVROBIO and Tectonic Therapeutic Announce Merger Business Wire

Tectonic Therapeutic Launches with $80 Million Series A Financing to Transform the Discovery of Novel G-Protein Coupled Receptor (GPCR)-Targeted Therapies - Business Wire

Tectonic Therapeutic Launches with $80 Million Series A Financing to Transform the Discovery of Novel G-Protein Coupled Receptor (GPCR)-Targeted Therapies Business Wire

Top Tectonic Therapeutic, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant